Skip to search formSkip to main contentSkip to account menu

itopride

Known as: N-(p-(2-(Dimethylamino)ethoxy)benzyl)veratramide, N-(p-(2-(dimethylamino)ethoxy)benzyl)veratramide hydrochloride 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Itopride, a prokinetic with dopamine D2‐antagonistic and cholinesterase inhibitor properties, is used for treating functional… 
2013
2013
Itopride HCl (ITO) is a novel prokinetic agent, currently used for the treatment of various gastrointestinal motility disorders… 
2012
2012
Recent whole-genome sequencing efforts have facilitated the detailed characterisation of the human degradome consisting of almost… 
2011
2011
AbstractBackground: Prokinetic agents are commonly used in the symptomatic treatment of functional dyspepsia (FD). Safety or… 
2011
2011
Degradation products of itopride formed under different forced conditions have been identified using LC-PDA and LC-MS techniques… 
2010
2010
Abstract In the present study two different formulations containing 50 mg itopride HCl (N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4… 
Review
2008
Review
2008
The publication in this issue of Gut ( see page 10.1136/gut.2007.132449 ) of the results of the clinical trial programme… 
2005
2005
AIM: To evaluate the efficacy and safety of itopride in the treatme nt for functional dyspepsia. METHODS: Two hundred and nine…